logo

For the Inventor, By the Inventor

V.ae butted.rl.o slashed.se, Denmark

Ole Buchardt, Deceased

This inventor holds 10 USPTO granted patents. Top assignees: Boehringer Mannheim Gmbh, Other. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Buchardt, Deceased. Retrieved from https://idiyas.com/inventor/ole-buchardt-deceased

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 1,465(Granted Patents)


Location History:

  • late of Yaerlose, DK (1998)
  • late of V.ae butted.rl.o slashed.se, DK (1998)
  • late of 3500 V.ae butted.rl.o slashed.se, DK (1998)
  • late of DK 3500 Vaerlose, DK (1999)
  • late of Vaerlose, DK (1999)
  • late of Vaelose, DK (2000)

Company Filing History:

goldMedal1 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
silverMedal9 out of 834,513 
Other
 patents

Years Active: 1998-2000

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6107470 - Histidine-containing peptide nucleic acids (2000-08-22),
2. 5977296 - Chiral peptide nucleic acid monomers and oligomers (1999-11-02),
3. 5972610 - Use of nucleic acid analogues in the inhibition of nucleic acid (1999-10-26),
4. 5891625 - Use of nucleic acid analogues in the inhibition of nucleic acid (1999-04-06),
5. 5837459 - Nucleic acid analogue induced transcription of double stranded DNA (1998-11-17),
6. 5786461 - Peptide nucleic acids having amino acid side chains (1998-07-28),
7. 5766855 - Peptide nucleic acids having enhanced binding affinity and sequence (1998-06-16),
8. 5736336 - Peptide nucleic acids having enhanced binding affinity, sequence (1998-04-07),
9. 5719262 - Peptide nucleic acids having amino acid side chains (1998-02-17),
10. 5714331 - Peptide nucleic acids having enhanced binding affinity, sequence (1998-02-03),

Title: The Innovative Contributions of Ole Buchardt

Introduction

Ole Buchardt was a notable inventor whose work significantly impacted the field of peptide nucleic acids. He held a total of 10 patents, showcasing his innovative spirit and dedication to scientific advancement. His contributions have paved the way for new applications in diagnostics, research, and therapeutics.

Latest Patents

Among his latest patents, Buchardt developed histidine-containing peptide nucleic acids. These peptide nucleic acids, which include histidine moieties, have various applications, including diagnostics and potential therapeutics. Additionally, he synthesized a novel class of chiral peptide nucleic acid monomers and oligomers, incorporating chirality in the backbone, which further enhances the functionality of peptide nucleic acids.

Career Highlights

Throughout his career, Ole Buchardt worked with prominent companies, including Boehringer Mannheim GmbH. His innovative research and development efforts have made significant contributions to the scientific community, particularly in the area of peptide nucleic acids.

Collaborations

Buchardt collaborated with esteemed colleagues such as Peter Eigil Nielsen and Michael Egholm. Their combined expertise and efforts have led to advancements in the field, further solidifying Buchardt's legacy as an influential inventor.

Conclusion

Ole Buchardt's innovative work in peptide nucleic acids has left a lasting impact on the scientific community. His patents and collaborations have opened new avenues for research and potential therapeutic applications. His contributions will continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…